Assignee
ELAN PHARM INC
US·181 granted patents·50 pending applications·4,011 citations·filing 1992–2015
Top patents by PatentIndex Score
231 records- 0198US7910333B2Antibodies to alpha-synucleinELAN PHARM INC·Filed 2010·Granted Mar 22, 2011·52 cites·9 claims
- 0298US7524812B2Pharmaceutical formulation comprising ziconotideELAN PHARM INC·Filed 2007·Granted Apr 28, 2009·92 cites·20 claims
- 0398US7049306B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.ELAN PHARM INC·Filed 2002·Granted May 23, 2006·90 cites·6 claims
- 0497US7928203B2Chimeric, humanized, or human antibody 2A4ELAN PHARM INC·Filed 2008·Granted Apr 19, 2011·38 cites·3 claims
- 0596US8349321B2Immunoglobulin formulation and method of preparation thereofELAN PHARM INC·Filed 2009·Granted Jan 8, 2013·65 cites·4 claims
- 0696US7674599B2Methods of using antibodies to detect alpha-synuclein in fluid samplesELAN PHARM INC·Filed 2004·Granted Mar 9, 2010·49 cites·11 claims
- 0796US5942400AAssays for detecting β-secretaseELAN PHARM INC·Filed 1996·Granted Aug 24, 1999·278 cites·5 claims
- 0895US7977316B2Prevention and treatment of amyloidogenic diseasesELAN PHARM INC·Filed 2007·Granted Jul 12, 2011·19 cites·20 claims
- 0995US7807167B2Administration of agents for the treatment of inflammationELAN PHARM INC·Filed 2006·Granted Oct 5, 2010·37 cites·11 claims
- 1095US7358331B2Truncated fragments of alpha-synuclein in Lewy body diseaseELAN PHARM INC·Filed 2005·Granted Apr 15, 2008·43 cites·11 claims
- 1195US7268109B2Method for reducing painELAN PHARM INC·Filed 2004·Granted Sep 11, 2007·48 cites·6 claims
- 1295US6492372B1Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Dec 10, 2002·49 cites·6 claims
- 1395US6436904B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Aug 20, 2002·39 cites·32 claims
- 1495US6407066B1Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Jun 18, 2002·52 cites·16 claims
- 1595US6407128B1Method for increasing the bioavailability of metaxaloneELAN PHARM INC·Filed 2001·Granted Jun 18, 2002·75 cites·22 claims
- 1695US6245964B1Transgenic rodent comprising APP-SwedishELAN PHARM INC·Filed 1998·Granted Jun 12, 2001·82 cites·15 claims
- 1795US6114133AMethods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)ELAN PHARM INC·Filed 1994·Granted Sep 5, 2000·187 cites·20 claims
- 1895US6033665ACompositions and methods for modulating leukocyte adhesion to brain endothelial cellsELAN PHARM INC·Filed 1995·Granted Mar 7, 2000·141 cites·13 claims
- 1994US7919088B2Treatment and delay of onset of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2007·Granted Apr 5, 2011·40 cites·15 claims
- 2094US7427628B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2006·Granted Sep 23, 2008·23 cites·14 claims
- 2194US6683102B2Methods of using metaxalone in the treatment of musculoskeletal conditionsELAN PHARM INC·Filed 2002·Granted Jan 27, 2004·53 cites·15 claims
- 2294US6509331B1Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsELAN PHARM INC·Filed 1999·Granted Jan 21, 2003·81 cites·45 claims
- 2394US6479492B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Nov 12, 2002·41 cites·7 claims
- 2493US6982264B2Substituted alcohols useful in treatment of Alzheimer's diseaseELAN PHARM INC·Filed 2002·Granted Jan 3, 2006·38 cites·10 claims
- 2593US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 2693US6284221B1Method for identifying β-amyloid peptide production inhibitorsELAN PHARM INC·Filed 1996·Granted Sep 4, 2001·132 cites·9 claims
- 2792US7005433B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2003·Granted Feb 28, 2006·27 cites·9 claims
- 2892US6627739B1β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2000·Granted Sep 30, 2003·48 cites·1 claims
- 2992US6221645B1β-secretase antibodyELAN PHARM INC·Filed 1996·Granted Apr 24, 2001·95 cites·5 claims
- 3092US6191166B1Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesisELAN PHARM INC·Filed 1997·Granted Feb 20, 2001·83 cites·31 claims
- 3191US7262043B2β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2005·Granted Aug 28, 2007·9 cites·4 claims
- 3291US6974829B2Succinoyl aminopyrazoles and related compoundsELAN PHARM INC·Filed 2003·Granted Dec 13, 2005·33 cites·8 claims
- 3390US7135477B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Nov 14, 2006·28 cites·9 claims
- 3490US7034182B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Apr 25, 2006·37 cites·45 claims
- 3590US6018024AMethods and compositions for monitoring cellular processing of beta-amyloid precursor proteinELAN PHARM INC·Filed 1997·Granted Jan 25, 2000·69 cites·3 claims
- 3690US5891849AMethods and formulations for preventing progression of neuropathic painELAN PHARM INC·Filed 1997·Granted Apr 6, 1999·94 cites·10 claims
- 3789US7727997B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·21 cites·27 claims
- 3889US7312360B2Substituted hydroxyethylaminesELAN PHARM INC·Filed 2002·Granted Dec 25, 2007·39 cites·11 claims
- 3989US6136786AMethod for enhancing analgesiaELAN PHARM INC·Filed 1999·Granted Oct 24, 2000·52 cites·6 claims
- 4088US7223774B2Benzamide 2-hydroxy-3-diaminoalkanesELAN PHARM INC·Filed 2004·Granted May 29, 2007·34 cites·13 claims
- 4188US6689781B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2001·Granted Feb 10, 2004·27 cites·9 claims
- 4288US6616914B2Method for pulmonary and oral delivery of pharmaceuticalsELAN PHARM INC·Filed 2001·Granted Sep 9, 2003·32 cites·23 claims
- 4388US6455557B1Method of reducing somnolence in patients treated with tizanidineELAN PHARM INC·Filed 2001·Granted Sep 24, 2002·35 cites·21 claims
- 4487US7205310B2Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted Apr 17, 2007·11 cites·19 claims
- 4587US6664442B2Selecting compounds to reduce inflammation associated with Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Dec 16, 2003·29 cites·43 claims
- 4687US6329163B1Assays for detecting β-secretase inhibitionELAN PHARM INC·Filed 1998·Granted Dec 11, 2001·68 cites·15 claims
- 4786US7601528B1Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's diseaseELAN PHARM INC·Filed 2005·Granted Oct 13, 2009·13 cites·2 claims
- 4886US7335663B2Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Feb 26, 2008·19 cites·8 claims
- 4986US6545003B1Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Apr 8, 2003·23 cites·7 claims
- 5086US6451828B1Selective inhibition of glutaminase by bis-thiadiazolesELAN PHARM INC·Filed 2001·Granted Sep 17, 2002·30 cites·15 claims
Showing the top 50 of 231 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ELAN PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →